The Stratus variant is fueling COVID-19 cases around the country. Symptoms of the virus look slightly different right now. Here, doctors share what to look out for and how to protect yourself from the ...
A newer COVID variant called XFG is currently fueling cases of the virus across the country. Nicknamed “Stratus,” this variant first took hold over the summer and now makes up nearly 70% of COVID-19 ...
You may find yourself reaching for tissues and a thermometer during the winter months, wondering what has you under the weather. As flu and cold season arrives, Michiganders face other illnesses like ...
If you've ever sat in your car and noticed that your dashboard looks like it's been through a dust storm and a fryer basket, you're not alone. Most dashboards don't just degrade overnight. They lose ...
The U.S. Food and Drug Administration plans to change how COVID vaccines and other shots are approved and administered. The memo, which was written by FDA chief medical and scientific officer Vinay ...
Researchers at the Icahn School of Medicine at Mount Sinai and collaborators have created the most comprehensive map to date showing how antibodies attach to the SARS-CoV-2 virus, which causes ...
Federal administration has thrown question into provisions for the COVID-19 vaccine, but state officials have moved to protect its coverage in Massachusetts. This past September, Massachusetts ...
As we get into another winter holiday season, COVID is still part of our lives. And although it's hard to predict exactly what this year's cold, flu and coronavirus season will look like, experts want ...
This article was republished with permission from WTOP’s news partners at Maryland Matters. Sign up for Maryland Matters’ free email subscription today. Maryland health officials launched a new data ...
A new study reveals that SARS-CoV-2 mRNA vaccines can amplify immune checkpoint therapy in lung and skin cancers by unleashing a potent interferon-driven immune surge that transforms resistant tumors ...
Oct 22 (Reuters) - Cancer patients who received mRNA-based COVID vaccines within 100 days of starting treatment with widely used immunotherapies were twice as likely to be alive three years after ...